Jane Street Group, LLC Mirum Pharmaceuticals, Inc. Call Options Transaction History
Jane Street Group, LLC
- $384 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding MIRM
# of Institutions
223Shares Held
55.4MCall Options Held
27.4KPut Options Held
105K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.8MShares$305 Million19.27% of portfolio
-
Janus Henderson Group PLC London, X04.77MShares$214 Million0.12% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$145 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$126 Million5.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.54MShares$114 Million0.0% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.65B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...